ez C., Soto-Rojas AE, Celis-Aguilar E., S? Nchez-Guerrero J. Association between dental caries and pneumonia in patients with systemic lupus erythematosus / / J. Rheumatol. 2006. Vol. 33 (10). Р. 1996-2002.
22. Listing J., Strangfeld A., Kary S., Rau R., von Hinueber U., Stoyanova-Scholz M., Grom-nica-Ihle E., Antoni C., Herzer P., Kekow J., Schneider M., Zink A. Infections in Patients With Rheumatoid Arthritis Treated With Biologic Agents / / Arthritis Rheum. 2005. Vol. 52 (11). Р. 3403-3412.
23. Salliot C., Gossec L., Ruyssen-Witrand A., Luc M., Duclos M., Guignard S., Dougados M. Infections during tumour necrosis factor blocker therapy for rheumatic diseases in daily prac-tice: a systematic retrospective study of 709 patients / / Rheumatology. 2007. Vol. 46. ??Р. 327-334.
24. P? Rez-Sola MJ, Torre-Cisneros J., P? Rez-Zafrilla B., Carmona L., Descalzo MA, G? Mez-Reino JJ; BIOBADASER Study Group. nfections in patients treated with tumor necro-sis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry / / Med Clin (Barc). 2011. Vol. 137 (12). Р. 533-540.
25. Lane MA, McDonald JR, Zeringue AL, Caplan L., Curtis JR, Ranganathan P., Eisen SATNF-? antagonist use and risk of hospitalization for infection in a national cohort of veter-ans with rheumatoid arthritis / / Medicine. 2011. Vol. 90 (2). Р. 139-145.
26. Van Dartel SA, Fransen J., Kievit W., Dutmer EA, Brus HL, Houtman NM, van de Laar MA, van Riel PL Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry / / Rheumatology. 2013 Jan 30. [Epub ahead of print].
27. Van Vollenhoven R.F., Emery P., Bingham C.O. 3rd, Keystone EC, Fleischmann RM, Furst DE, Tyson N., Collinson N., Lehane PB Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients / / Ann Rheum Dis. 2012 Nov 7. [Epub ahead of print].
28. Hoshi D., Nakajima A., Inoue E., Shidara K., Sato E., Kitahama M., Seto Y., Tanaka E., Urano W., Ichikawa N., Koseki Y., Momohara S., Taniguchi A., Nishimoto N., Yamanaka H. Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with to-cilizumab / / Mod Rheumatol. 2012. Vol. 22 (1). Р. 122-127.
29. Mori S., Sugimoto M. Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis Rheumatology (Oxford). 2012. Vol. 51 (12). Р. 2120-2130.
30. Wissmann G., Morilla R., Mart? N-Garrido I., Friaza V., Respaldiza N., Povedano J., Praena-Fern? Ndez JM, Montes-Cano MA, Medrano FJ, Goldani LZ, de la Horra C., Varela JM, Calder? n EJ Pneumocystis jirovecii colonization in patients treated with infliximab / / Eur J Clin Invest. 2011 Mar. Vol. 41 (3). Р. 343-348.
31. Mekinian A., Durand-Joly I., Hatron PY, Moranne O., Denis G., Dei-Cas E., Morell-Dubois S., Lambert M., Launay D., Delhaes L., Hachulla E. , Queyrel V. Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: prevalence, risk factors of coloniza-tion and outcome / / Rheumatology (Oxford). 2011. Vol. 50 (3). Р. 569-577.
32. Fritzsche C., Riebold D., Munk-Hartig A., Klammt S., Neeck G., Reisinger E. Hig...
